tenk.fyi

CERO THERAPEUTICS HOLDINGS, INC.

CEROOTC· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$7.7M

6.1% YoY

EPS

$-18.15

98.5% YoY

Cash

$3.3M

107.8% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro